MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.04MP/E –Yield –
MiMedx gross margin
Gross margin is gross profit as a percentage of revenue.
MiMedx's gross margin for the twelve months ending Sep 30, 2026 was 77.3%. For fiscal 2025 it was 82.6%, against 82.8% the year before. The highest annual figure on record is 89.9% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 82.6% | −0.2 |
| FY2024 | Dec 31, 2024 | 82.8% | −0.2 |
| FY2023 | Dec 31, 2023 | 83.0% | +1.0 |
| FY2022 | Dec 31, 2022 | 82.0% | −1.7 |
| FY2021 | Dec 31, 2021 | 83.6% | −0.5 |
| FY2020 | Dec 31, 2020 | 84.2% | −1.4 |
| FY2019 | Dec 31, 2019 | 85.6% | −4.3 |
| FY2018 | Dec 31, 2018 | 89.9% | +0.8 |
| FY2017 | Dec 31, 2017 | 89.0% | +3.0 |
| FY2016 | Dec 31, 2016 | 86.0% | −3.2 |
| FY2015 | Dec 31, 2015 | 89.2% | −0.1 |
| FY2014 | Dec 31, 2014 | 89.3% | +5.0 |
| FY2013 | Dec 31, 2013 | 84.2% | +3.4 |
| FY2012 | Dec 31, 2012 | 80.8% | +24.1 |
| FY2011 | Dec 31, 2011 | 56.7% | +174.8 |
| FY2010 | Dec 31, 2010 | -118.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 79.8% | −3.7 |
| Q2 FY2026 | Jun 30, 2026 | 69.0% | −12.1 |
| Q1 FY2026 | Mar 31, 2026 | 70.6% | −10.7 |
| Q4 FY2025 | Dec 31, 2025 | 83.9% | +2.1 |
| Q3 FY2025 | Sep 30, 2025 | 83.5% | +1.8 |
| Q2 FY2025 | Jun 30, 2025 | 81.1% | −1.9 |
| Q1 FY2025 | Mar 31, 2025 | 81.2% | −3.4 |
| Q4 FY2024 | Dec 31, 2024 | 81.8% | −2.3 |
| Q3 FY2024 | Sep 30, 2024 | 81.8% | −0.1 |
| Q2 FY2024 | Jun 30, 2024 | 83.0% | −0.3 |
| Q1 FY2024 | Mar 31, 2024 | 84.7% | +2.0 |
| Q4 FY2023 | Dec 31, 2023 | 84.1% | +3.4 |
| Q3 FY2023 | Sep 30, 2023 | 81.9% | −0.1 |
| Q2 FY2023 | Jun 30, 2023 | 83.3% | +1.0 |
| Q1 FY2023 | Mar 31, 2023 | 82.7% | −0.5 |
| Q4 FY2022 | Dec 31, 2022 | 80.7% | −5.4 |
| Q3 FY2022 | Sep 30, 2022 | 82.0% | −1.9 |
| Q2 FY2022 | Jun 30, 2022 | 82.3% | +1.0 |
| Q1 FY2022 | Mar 31, 2022 | 83.1% | −0.8 |
| Q4 FY2021 | Dec 31, 2021 | 86.0% | +1.8 |
| Q3 FY2021 | Sep 30, 2021 | 83.9% | −0.1 |
| Q2 FY2021 | Jun 30, 2021 | 81.3% | −3.4 |
| Q1 FY2021 | Mar 31, 2021 | 83.9% | +0.2 |
| Q4 FY2020 | Dec 31, 2020 | 84.2% | +0.9 |
| Q3 FY2020 | Sep 30, 2020 | 84.0% | −1.1 |
| Q2 FY2020 | Jun 30, 2020 | 84.7% | −0.8 |
| Q1 FY2020 | Mar 31, 2020 | 83.8% | −5.1 |
| Q4 FY2019 | Dec 31, 2019 | 83.4% | −5.4 |
| Q3 FY2019 | Sep 30, 2019 | 85.1% | −6.4 |
| Q2 FY2019 | Jun 30, 2019 | 85.5% | −4.7 |
| Q1 FY2019 | Mar 31, 2019 | 88.9% | −0.0 |
| Q4 FY2018 | Dec 31, 2018 | 88.8% | −0.5 |
| Q3 FY2018 | Sep 30, 2018 | 91.5% | +2.6 |
| Q2 FY2018 | Jun 30, 2018 | 90.3% | +0.8 |
| Q1 FY2018 | Mar 31, 2018 | 88.9% | +0.6 |
| Q4 FY2017 | Dec 31, 2017 | 89.3% | +2.3 |
| Q3 FY2017 | Sep 30, 2017 | 88.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 89.5% | – |
| Q1 FY2017 | Mar 31, 2017 | 88.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 87.0% | – |
See a number that looks wrong?